Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-26

FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Betaseron (interferon beta-1b) submitted by Bayer HealthCare Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaseron (Interferon beta-1b)

Snippet

SUPPL AP for BETASERON (INTERFERON BETA-1B)